Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: A double-blind, randomized, placebo-controlled trial

Fertility and Sterility

Volumn 95, Issue 5, 2011, Pages 1849-1852

  Raja Khan, Nazia ^a   Kunselman, Allen R ^a   Hogeman, Cynthia S ^a   Stetter, Christy M ^a   Demers, Laurence M ^a   Legro, Richard S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Hyperandrogenemia; hyperinsulinemia; PCOS; statin; vascular function

Indexed keywords

ANDROGEN; ATORVASTATIN; INSULIN;

ADULT; ARTERY BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPEREMIA; INFLAMMATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADULT; ANDROGENS; ANTICHOLESTEREMIC AGENTS; BLOOD VESSELS; DOUBLE-BLIND METHOD; FEMALE; HEPTANOIC ACIDS; HUMANS; INFLAMMATION; PLACEBOS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PYRROLES; YOUNG ADULT;

EID: 79952992901     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.11.040     Document Type: Article

References (32)

1. R.S. Legro, A.R. Kunselman, W.C. Dodson, and A. Dunaif Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome Am J Med 111 2001 607 613 (Pubitemid 34088070)
2. E. Diamanti-Kandarakis, A.G. Papavassiliou, S.A. Kandarakis, and G.P. Chrousos Pathophysiology and types of dyslipidemia in PCOS Trends Endocrinol Metab 18 2007 280 285 (Pubitemid 47332216)
3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
4. D. Izquierdo, N. Foyouzi, J. Kwintkiewicz, and A.J. Duleba Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis Fertil Steril 82 Suppl 3 2004 1193 1197 (Pubitemid 39335938)
5. I.J. Rzepczynska, P.C. Piotrowski, D.H. Wong, A.B. Cress, J. Villanueva, and A.J. Duleba Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat Biol Reprod 81 2009 850 855
6. T. Kazerooni, A. Shojaei-Baghini, S. Dehbashi, N. Asadi, F. Ghaffarpasand, and Y. Kazerooni Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study Fertil Steril 94 2010 2208 2213
7. B. Banaszewska, L. Pawelczyk, R.Z. Spaczynski, and A.J. Duleba Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial J Clin Endocrinol Metab 94 2009 4938 4945
8. C. Kaya, S.D. Cengiz, B. Berker, S. Demirtas, M. Cesur, and G. Erdogan Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study Fertil Steril 92 2009 635 642
9. T. Sathyapalan, E.S. Kilpatrick, A.M. Coady, and S.L. Atkin The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study J Clin Endocrinol Metab 94 2009 103 108
10. A.J. Duleba, B. Banaszewska, R.Z. Spaczynski, and L. Pawelczyk Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial Fertil Steril 85 2006 996 1001
11. J. Shepherd, P. Barter, R. Carmena, P. Deedwania, J.C. Fruchart, and S. Haffner Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study Diabetes Care 29 2006 1220 1226 (Pubitemid 44125913)
12. J. Davignon Beneficial cardiovascular pleiotropic effects of statins Circulation 109 2004 III39 III43
13. R. Collins, J. Armitage, S. Parish, P. Sleigh, and R. Peto MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
14. L.A. Simons, D. Sullivan, J. Simons, and D.S. Celermajer Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia Atherosclerosis 137 1998 197 203 (Pubitemid 28175392)
15. G. O'Driscoll, D. Green, and R.R. Taylor Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month Circulation 95 1997 1126 1131 (Pubitemid 27097821)
16. R.A. Vogel, M.C. Corretti, and G.D. Plotnick Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men Am J Cardiol 77 1996 37 40 (Pubitemid 26011629)
17. M.C. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, and M.A. Creager Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265 (Pubitemid 34084631)
18. M. Al-Qaisi, R.K. Kharbanda, T.K. Mittal, and A.E. Donald Measurement of endothelial function and its clinical utility for cardiovascular risk Vasc Health Risk Manag 4 2008 647 652 (Pubitemid 352037922)
19. M.L. Bots, J. Westerink, T.J. Rabelink, and E.J. de Koning Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response Eur Heart J 26 2005 363 368 (Pubitemid 40283095)
20. N. Gokce, J.F. Keaney Jr., L.M. Hunter, M.T. Watkins, Z.S. Nedeljkovic, and J.O. Menzoian Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease J Am Coll Cardiol 41 2003 1769 1775 (Pubitemid 36584251)
21. Hirsch L, Shechter A, Feinberg MS, Koren-Morag N, Shechter M. The impact of early compared to late morning hours on brachial endothelial function and long-term cardiovascular events in healthy subjects with no apparent coronary heart disease. Int J Cardiol 2010 [Epub ahead of print].
22. Y. Inaba, J.A. Chen, and S.R. Bergmann Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis Int J Cardiovasc Imaging 26 2010 631 640
23. J.K. Zawadski, and A. Dunaif Diagnostic criteria for polycystic ovary syndrome J.H.F. Givens, G. Merriman, The polycystic ovary syndrome 1992 Blackwell Scientific Cambridge, MA 377 384
24. R. Hatch, R.L. Rosenfield, M.H. Kim, and D. Tredway Hirsutism: implications, etiology, and management Am J Obstet Gynecol 140 1981 815 830 (Pubitemid 11046650)
25. Raja-Khan N, Shuja SA, Kunselman AR, Hogeman CS, Demers LM, Gnatuk CL, et al. Brachial artery conductance during reactive hyperemia is increased inwomen with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. Published online November 16, 2010.
26. J.W. Mason, J.A. Florian Jr., C.E. Garnett, T.E. Moon, D.S. Selness, and R.R. Spaulding Pharmacokinetics and pharmacodynamics of three moxifloxacin dosage forms: implications for blinding in active-controlled cardiac repolarization studies J Clin Pharmacol 50 2010 1249 1259
27. A.L. Moens, I. Goovaerts, M.J. Claeys, and C.J. Vrints Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest 127 2005 2254 2263
28. K.E. Sorensen, D.S. Celermajer, D.J. Spiegelhalter, D. Georgakopoulos, J. Robinson, and O. Thomas Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility Br Heart J 74 1995 247 253
29. S.N. Rajpathak, D.J. Kumbhani, J. Crandall, N. Barzilai, M. Alderman, and P.M. Ridker Statin therapy and risk of developing type 2 diabetes: a meta-analysis Diabetes Care 32 2009 1924 1929
30. N. Sattar, D. Preiss, H.M. Murray, P. Welsh, B.M. Buckley, and A.J. de Craen Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 375 2010 735 742
31. B.M. Everett, R.J. Glynn, J.G. MacFadyen, and P.M. Ridker Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) Circulation 121 2010 143 150
32. R.A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H.F. Escobar-Morreale, and W. Futterweit Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society J Clin Endocrinol Metab 95 2010 2038 2049